Mill Creek Capital Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1964962 Conshohocken, PA

Position in JNJ

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$55,643,099

+$6,369,132 QoQ

Shares Held

227,635

-4.4% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

11.38%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Mill Creek Capital Advisors, LLC holds $59,193,747 across 6 Drug Manufacturers - General names. JNJ ranks #1 (94.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	227,635	$55,643,099
2	AMGN	Amgen Inc	4,238	$1,491,140
3	MRK	Merck & Co., Inc.	5,935	$713,921
4	LLY	ELI LILLY & Co	614	$564,738
5	ABBV	AbbVie Inc.	1,821	$396,049
6	GILD	Gilead Sciences, Inc.	2,761	$384,800

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$55,643,099	227,635	-4.4%	Shares	Sole	2026-05-14
2025-12-31	$49,273,967	238,096	-0.4%	Shares	Sole	2026-02-13
2025-09-30	$44,339,113	239,128	-0.0%	Shares	Sole	2025-11-12
2025-06-30	$36,530,009	239,149	+0.4%	Shares	Sole	2025-08-11
2025-03-31	$39,501,761	238,192	-4.2%	Shares	Sole	2025-05-13
2024-12-31	$35,961,353	248,661	+0.5%	Shares	Sole	2025-01-29
2024-09-30	$40,112,605	247,517	-3.0%	Shares	Sole	2024-11-06
2024-06-30	$37,292,431	255,148	-3.1%	Shares	Sole	2024-08-14
2024-03-31	$41,662,974	263,373	+2.6%	Shares	Sole	2024-05-14
2023-12-31	$40,252,712	256,812	-0.3%	Shares	Sole	2024-02-14
2023-09-30	$40,116,683	257,571	-6.7%	Shares	Sole	2023-11-14
2023-06-30	$45,710,499	276,163	-4.5%	Shares	Sole	2023-08-14
2023-03-31	$44,820,110	289,162	-0.3%	Shares	Sole	2023-05-15
2022-12-31	$51,214,191	289,919	—	Shares	Sole	2023-05-25
No filing history on record for this holder in this stock.